Uremic bleeding: closing the circle after 30 years of controversies?
Noris
M
M
Mario Negri Institute for Pharmacological Research, Bergamo, Italy.
Remuzzi
G
G
D000740:Anemia / Q000188:drug therapy / Q000209:etiology / Q000266:history; D000818:Animals; D001120:Arginine / Q000378:metabolism; D001760:Bleeding Time; D001792:Blood Platelets / Q000187:drug effects; D004730:Endothelium, Vascular / Q000187:drug effects / Q000378:metabolism; D004791:Enzyme Inhibitors / Q000494:pharmacology; D004921:Erythropoietin / Q000627:therapeutic use; D006146:Guanidines / Q000097:blood* / Q000494:pharmacology; D006470:Hemorrhage / Q000209:etiology* / Q000266:history; D049671:History, 18th Century; D049673:History, 20th Century; D006801:Humans; D007527:Isoenzymes / Q000037:antagonists & inhibitors / Q000378:metabolism; D007676:Kidney Failure, Chronic / Q000097:blood / Q000150:complications; D009569:Nitric Oxide / Q000378:metabolism; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors / Q000378:metabolism; D019335:Nitroarginine / Q000494:pharmacology; D051381:Rats; D013386:Succinates / Q000097:blood* / Q000494:pharmacology; D014511:Uremia / Q000097:blood / Q000150:complications* / Q000188:drug therapy / Q000266:history; D019323:omega-N-Methylarginine / Q000494:pharmacology / Q000627:therapeutic use
D004791:Enzyme Inhibitors; D006146:Guanidines; D007527:Isoenzymes; D013386:Succinates; D004921:Erythropoietin; D019335:Nitroarginine; D019323:omega-N-Methylarginine; D009569:Nitric Oxide; C001318:guanidinosuccinic acid; D001120:Arginine; D019001:Nitric Oxide Synthase